Regulation of immunolabelled μ-opioid receptors and protein kinase C-α and ζ isoforms in the frontal cortex of human opiate addicts

Neuroscience Letters

Volumn 226, Issue 1, 1997, Pages 29-32

  García Sevilla, Jesús A ^a,b   Ventayol, Pere ^b   Busquets, Xavier ^b   La Harpe, Romano ^a   Walzer, Claude ^a   Guimón, José ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

Author keywords

Opioid receptors; G (i 1 4 ) proteins; Human brain; Opiate addiction; Protein kinase C and isoforms; Western immunoblot

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; ISOENZYME; MU OPIATE RECEPTOR; PROTEIN KINASE C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MALE; OPIATE ADDICTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; FEMALE; FRONTAL LOBE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN KINASE C; RECEPTORS, OPIOID, MU; SUBSTANCE-RELATED DISORDERS;

EID: 0343924420     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00227-9     Document Type: Article

References (20)

1. Brodsky, M., Elliot, K., Hynansky, A. and Inturrisi, C.E., CNS levels of mu opioid receptor (MOR-1) mRNA during chronic treatment with morphine or naltrexone, Brain Res. Bull., 38 (1995) 135-141.
2. Busquets, X., Escribá, P.V., Sastre, M. and García-Sevilla, J.A., Loss of protein kinase C-αβ in brain of heroin addicts and morphine-dependent rats, J. Neurochem., 64 (1995) 247-252.
3. Buzas, B., Rosenberger, J. and Cox, B.M., Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist, NeuroReport, 7 (1996) 1505-1508.
4. Escribá, P.V., Sastre, M. and García-Sevilla, J.A., Increased density of guanine nucleotide-binding proteins in the postmortem brains of heroin addicts, Arch. Gen. Psychiat., 51 (1994) 494-501.
5. 2-adrenoceptor agonist binding sites in the postmortem brain of heroin addicts, Psychopharmacology, 115 (1994) 135-140.
6. 2-Adrenoceptor-mediated inhibition of platelet adenylate cyclase activity in heroin addicts in abstinence, Psychopharmacology, 92 (1987) 320-323.
7. García-Sevilla, J.A., Ventayol, P., Busquets, X., La Harpe, R., Walzer, C. and Guimón J. Marked decrease of immunolabelled 68-kDa neurofilament (NF-L) proteins in brains of opiate addicts, NeuroReport, (1997) in press.
8. Garzón, J., Juarros, J.L., Castro, M.A. and Sánchez-Blázquez, P., Antibodies to the cloned μ-opioid receptor detect various molecular weight forms in areas of mouse brain, Mol. Pharmacol., 47 (1995) 738-744.
9. Garzón, J. and Sánchez-Blázquez, P., In vivo injection of antibodies directed against the cloned μ-opioid receptor blocked supraspinal analgesia induced by μ-agonists in mice, Life Sci., 56 (1995) 237-242.
10. Liu, J.-P., Protein kinase C and its substrates, Mol. Cell. Endocrinol., 116 (1996) 1-29.
11. Maldonado, R., Blendy, J.A., Tzavara, E., Gass, P., Roques, B.P., Hanoune, J. and Schütz, G., Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB, Science, 273 (1996) 657-659.
12. Matsuoka, I., Maldonado, R., Defer, N., Noel, F., Hanoune, J. and Roques, B.P., Chronic morphine administration causes region-specific increase of brain type VIII adenynyl cyclase mRNA, Eur. J. Pharmacol., 268 (1994) 215-221.
13. Matthes, H.W.D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., Tzavara, E., Hanoune, J., Roques, B.P. and Kieffer, B.L., Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene, Nature, 383 (1996) 819-823.
14. Nestler, E.J., Molecular mechanisms of drug addiction, J. Neurosci., 12 (1992) 2439-2450.
15. Nestler, E.J. and Tallman, J.F., Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus, Mol. Pharmacol., 33 (1988) 127-132.
16. Pak, Y., Kouvelas, A., Scheideler, M.A., Rasmussen, J., O'Dowd, B.F. and George, S.R., Agonist-induced functional desensitization of the μ-opioid receptor is mediated by loss of membrane receptors rather than uncoupling from G protein, Mol. Pharmacol., 50 (1996) 1214-1222.
17. Sánchez-Blázquez, P., Rodríguez, M.D. and Garzón, J., Antibodies directed against the mu-opioid receptor alleviated multiple signs of morphine withdrawal in mice, Life Sci., 59 (1996) PL87-PL92.
18. Sharma, S.K., Klee, W.A. and Niremberg, M., Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance, Proc. Natl. Acad. Sci. USA, 72 (1995) 3092-3096.
19. 2-adrenoceptor and μ-opioid receptor densities during morphine dependence and spontaneous withdrawal in rats, Naunyn-Schmiedeberg's Arch. Pharmacol., 336 (1987) 530-537.
20. Ventayol, P., Busquets, X. and García-Sevilla, J.A., Modulation of immunoreactive protein kinase C-α and β isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain, Naunyn-Schmiedeberg's Arch. Pharmacol., (1997) in press.